US EditionPublished • loading... • Updated
As GSK Shares Fall 5% on Q1 News, Is This a Buying Opportunity?
Summary by The Motley Fool UK
2 Articles
2 Articles
The invoicing of the period increased 5% in terms of the current exchange rate, to 7.63 billion pounds, compared to a consensus estimate of 7.58 billion pounds
·Brazil
Read Full Article
As GSK shares fall 5% on Q1 news, is this a buying opportunity?
GSK (LSE: GSK) beat first-quarter earnings expectations Wednesday (29 April), but the shares responded with a 5% drop. Highlights from the update included: Oncology sales up 28%, Shingrix vaccine sales up 20%. Full-year guidance reaffirmed. Over £40bn sales targeted by 2031. Some of the figures were a bit mixed, but I can’t help thinking investors might have missed the big picture. Let’s take a closer look. Sales up, but… Total sales in the qu…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right1Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
